- Steigert Gehirnaktivität und IQ
- Unterstützt und fördert Entgiftungsprozesse
- Wirkt verjüngend und stimmungsaufhellend
- Stimuliert und aktiviert die Hormondrüsen
- Fördert die Sensibilität und Kreativität
- Steigert motorische und kognitive Leistungsfähigkeit
Goldprozesse steuern das Herz-/Kreislaufsystem.
Kolloidales Gold wird gerne bei den depressiven Menschen verordnet, besonders bei denen, die sich in der Dunkelheit fürchten, sich vor eingebildetem Unheil ängstigen und zu Selbstvorwürfen sowie Lebensüberdruss neigen.
Im Körperlichen dominieren: Herzrhythmusstörungen, Blutandrang zum Kopf undrheumatische Schmerzen der Gelenke.
Der Patient mit gestörten Goldprozessen hat häufig Schlafstörungen und wacht gegen 4 Uhr morgens auf, um nicht mehr einzuschlafen.
Die Beschwerden verschlimmern sich in Ruhe, nachts und frühmorgens, bei Kälte und nach geistiger Anstrengung. Sie bessern sich in Wärme, im Freien und bei Bewegung.
Anti-Entzündungsmittel:
Kolloidales Gold ist ein Anti-Entzündungsmittel bei Darmentzündungen, Ekzemen, Akne, Herzinnenhautentzündung, bei allen durch Streptokokken verursachten Erkrankungen, bei der primär und sekundär chronischen Infekt-Arthritis, bei Gicht und Arthrose. Von Gold sagt man, dass es noch dort heilt, wo Antibiotika nicht mehr greifen. Während Antibiotika das Heilmittel Fieber unterdrückt und die Immunabwehr schwächt, aktiviert Gold die gesamte Abwehr.
Kolloidales Gold ist hilfreich bei allen entzündlichen und degenerativen Prozessen von Gelenken wie der primären und sekundären Polyarthritis, Spondylitis und auch Arthrose, sofern die Ursache sich im Herz-Blutsystem befindet.
Auch bei Hydrops der Gelenke und Herzwassersucht oder Pleuritis.
Schon die alten Ägypter nahmen Goldpulver bei körperlichen und seelischen Erkrankungen, die Priester und Pharaonen auch zur spirituellen Entwicklung. Die chinesische Akupunktur verwendet seit Jahrtausenden Goldnadeln, um über die Meridiane bestimmte Systeme und Organe im Körper anzuregen. Die Inkas und Mayas glaubten, durch Einnahme von Gold könnten sie die Lebensenergie aus der Sonne besser aufnehmen. Tatsächlich wirkt Gold ähnlich auf uns wie die Sonne.
Man sagt Gold auch nach, dass es innere Widerstände lösen kann. Deswegen verwendet man Gold häufig bei Tieren die mit veränderten Situationen nicht klarkommen, wie z. B. bei Pferden der Herdenwechsel oder Besitzerwechsel oder bei Tierschutzhunden die veränderterte Lebenssituation.
Studien und Artikel zu kolloidalem Gold
Studienübersicht und Artikel zum Thema kolloidales Gold
Effect of Colloidal Metallic Gold on Cognitive Functions: A Pilot Study Guy E. Abraham, MD; Souhaila A. McReynolds; Joel S. Dill, PhD Optimox Corporation, Torrance, California
Zusammenfassung: Um die Wirkung von kolloidalem metallischem Gold auf die kognitiven Funktionen zu bewerten, wurde die revidierte Wechsler-Intelligenz-Skalen-Testbatterie (WAIS-R) an 5 Probanden im Alter von 15 bis 45 Jahren vor, nach 4 Wochen auf kolloidalem Gold bei 30 mg/Tag und erneut 1 bis 3 Monate nach Absetzen des Goldpräparats durchgeführt. Die WAIS-R-Gesamtscores (I.Q) wurden berechnet, indem die Summe der verbalen Testscores zur Summe der Performance-Scores addiert wurde. Nach 4 Wochen mit kolloidalem Gold gab es eine 20%ige Steigerung der I.Q-Scores mit einem Mittelwert + SE von 112,8 + 2,3 vor Gold und 137 + 3,8, nach Gold (p <0,005). Sowohl die Leistungs- als auch die verbalen Testwerte trugen gleichermaßen zu diesem Anstieg der I.Q-Scores bei. Der Effekt des kolloidalen Goldes hielt bei drei Probanden nach ein- bis zweimonatigem Absetzen des Goldes an, während bei zwei Probanden, die die Tests drei Monate nach Absetzen des Goldes durchführten, die IQ-Werte auf das Ausgangsniveau zurückgingen.
Abstract
In order to evaluate the effect of colloidal metallic gold on cognitive functions, the revised Wechsler Intelligence scales battery of tests (WAIS-R) was administered to 5 subjects aged 15 to 45 years, before, after 4 weeks on colloidal gold at 30 mg/day and again 1 to 3 months off the gold preparation. The WAIS-R total scores (I.Q) were calculated by adding the sum of the verbal test scores to the sum of the performance scores. After 4 weeks on colloidal gold, there was a 20% increase in I.Q scores with mean + SE of 112.8 + 2.3 pre gold and 137 + 3.8, post gold (p <0.005). Both the performance and verbal test scores contributed equally to this increase in I.Q scores. The effect of the colloidal gold persisted in 3 subjects after 1 to 2 month off gold, where as in 2 subjects who took the tests 3 months after stopping the gold , I.Q scores were down to baseline levels.
Introduction
It is generally accepted that intelligence or cognitive functioning is the sum of many mental capacities. For this reason, tests that were developed to measure intelligence quotient (I.Q) comprised a series of subtests evaluating the several dimensions of intelligence. Of the several I.Q tests available, educators have found that the Full Scale I.Q score of the Wechsler intelligence scales (WIS) battery, which is calculated from the sum of the individual scores of 11 tests, (6 verbal and 5 performance tests) is an excellent predictor of academic achievement.1 The revised version of this I.Q test (WAIS-R) has been used extensively to assess the effect of deficiencies and supplementation of specific nutrients 2,3 and the effects of sex, race, age and education4-7 on mental performance. Gold is a precious metal which belongs to the transition group I in the periodic table and exists in nature in two basic forms: metallic gold and gold salts. Metallic gold is non-toxic, used extensively in dentistry and is widely available in colloidal form as a nutritional supplement for human consumption. One of us (GEA) has observed a significant subjective improvement of mental performance in 21 adult subjects after ingestion of a preparation of colloidal metallic gold (Aurasol®) for 3 to 9 months at a daily dosage of 15 mg of gold (unpublished). In order to use an objective and more standardized approach in evaluating the effect of colloidal gold on mental performance, the WAIS-R battery of tests7 was performed on 5 subjects (4 females, 1 male) age 15-45 years, before, during and after the ingestion of the same colloidal gold preparation at 30 mg/day. The results suggest that colloidal gold at 30 mg/day improved significantly the I.Q scores after only one month of administration.
Materials and Methods
Aqueous dispersion of colloidal metallic gold was prepared by a modification of the citrate reduction method of Frens. The concentration of gold in this preparation (Aurasol® ) was 30 mg per ounce of fluid.Five subjects were recruited for this study ( 4 females and 1 male) with ages ranging from 15 to 45 years. The subjects were evaluated using the WAIS-R procedure.7 Verbal scores, performance scores and total scores (I.Q) for each subject were calculated. The WAIS-R battery was performed on each subject before gold administration, after ingesting 30 mg of colloidal gold daily for one month, and again after being off the gold preparation for 1 to 3 months. The statistical significance of the data was assessed by Student’s paired t test.9
Results
The group of tests called verbal are non-learning and therefore is not influenced significantly by repetition. The performance tests can be learned with repetition and this should be taken into consideration when evaluating the results displayed in Table I. The mean scores + standard error (SE) were respectively for pre- and post-gold administration: verbal 61.4 + 2.4 and 75.4 + 4.5 (p<0.005); performance 51.4 + 0.83 and 61.6 + 1.9 (p<0.01); total scores (IQ) 112.8 + 2.3 and 137 + 3.8 (p<0.005). Since both the verbal (non-learning and performance (learning) scores contributed equally to the increased values observed in the total IQ scores following colloidal gold, the positive effect of colloidal gold cannot be attributed solely to learning the correct responses on the second test due to repetition.
It is of interest to note that in two subjects (#1 and #2) who repeated the battery 3 months after stopping colloidal gold, the total IQ scores were close to baseline pre-gold levels whereas, in 2 subjects who performed the test 1 month after stopping the gold, (#3 and #5) and in one subject (#4) who did so after 2 months off colloidal gold, the total IQ scores were still elevated above baseline, suggesting that the effect of the gold on mental performance has a carry-over of one to two months after stopping the use of this preparation.
Discussion
The WIS battery of tests is an excellent predictor of scholastic performance.1 In fact, according to Lezak,10 the average scores on a WIS battery provide just about as much information as do average scores on a school report card. We have observed a significant increase (20%) of the mean IQ scores in 5 subjects aged 15 to 45 years after only one month on oral colloidal metallic gold at 30 mg/day. This effect persisted for up to 2 months following discontinuation of the gold preparation. To our knowledge, this is the first study evaluating the effect of colloidal gold on mental performance. Possible mechanisms of action of the colloidal gold preparation are only speculative at this time. However, the potential applications of a non-toxic colloidal metal with marked and rapid positive effect on mental performance are without question of great practical value, not only in scholastic performance but also in the workplace.
The encouraging results of this pilot study warrant further evaluation of colloidal metallic gold in a larger number of subjects of different age groups. Testing various amounts of gold would assist in quantifying the response of the IQ tests in term of cumulative amount of gold ingested in order to investigate a possible dose-response relationship. Using the smallest amount of colloidal gold that results in a desirable effect on mental performance and scholastic achievement would keep the cost of such a program as low as possible.
References
Lezak, M.D., In: Neuropsychological Assessment. New York, Oxford University Press; 1995:690.
Goodwin, J.S., Goodwin, J.M., Garry, P.J. Association between nutritional status and cognitive functioning in a healthy elderly population. J Amer. Med. Assoc., 1983; 249:2917-2921.
Southon, S., Wright, A.J., Finglas, P.M., Bailey, A.L., et. al. Dietary intake and micronutrient status of adolescents: effect of vitamin and trace element supplementation on indices of status and performance in tests of verbal and non-verbal intelligence. Br. J. Nutr., 1994; 71:897-918.
Kaufman, A.S., McLean, J.E., Reynolds, C.R. Sex, race, residence, region, and education differences on the 11 WAIS-R subtests. J. Clin. Psychology, 1988; 44:231-248.
Kaufman, A.S., McLean, J., Reynolds, C. Analysis of WAIS-R factor patterns sex and race. J. Clin. Psychology, 1991; 47:548-557.
Kaufman, A.S., Reynolds, C.R., McLean, J.E. Age and WAIS-R intelligence in a national sample of adults in the 20 to 74 year age range: A cross-sectional analysis with educational level controlled. Intelligence, 1989; 13:235-253.
Kaufman, A.S. Assessing adolescent and adult intelligence. Boston, Allyn and Bacon Inc.; 1990.
Abraham, G.E., Himmel, P.B. Management of Rheumatoid Arthritis: Rationale for the Use of Colloidal Metallic Gold. In Press, J. Nutr. Med., 1997.
Huntsberger, D.V., Leaverton, P.E., In: Statistical Inference in the Biomedical Sciences. Boston, Allyn and Bacon Inc.; 1970:135.
Lezak, M.D., In: Neuropsychological Assessement. New York, Oxford University Press;1995:691.
Colloidal Gold in the Treatment of Rheumatoid Arthritis (RA) Peter B. Himmel, Jorge D. Flechas, Guy E. Abraham
Gold salts (aurothiolates) once the primary therapy for active RA has in recent years declined in its use because of apparent lack of long term efficacy, toxic side effects, and delayed onset of action. One of us (GEA) postulated that the active ingredient in aurothiolates is colloidal gold generated by in vivo disproportionation with subsequent clustering of monoatomic gold, and that the side effects were due to the aurothiolates themselves and the trivalent cationic gold generated from the disproportionation. If this postulate is valid one would expect colloidal gold to have therapeutic effects in RA and devoid of side effects.
Methods:
10 patients (6 female, 4 male; average age 50 +/- 3.16 (SE) with long standing erosive RA ( 9 of 10 seropositive) were given an oral dose of 30 to 60 mg a day of colloidal gold (Aurasol-tm) for a period of 1 month. Clinical exams were performed weekly and laboratory studies done on weeks 1, 2, 4. Gold toxicity was evaluated by questioning the patient as to pruritus, rashes, oral ulcers, metallic taste, GI disturbance. The blood was checked for a drop in WBC, Hb, platelet count, BUN, creatinine or eosinophil elevation; and urine for proteinuria. Efficacy was evaluated by an 86 Joint Count Index scoring for joint tenderness and swelling: AM stiffness; the Modified Health Assessment Questionnaire (MHAQII) by T. Pincus and an ESR.
Results:
Statistically significant improvement were found on each weekly exam for joint tenderness and swelling beginning with the first week 58.8 to 18.2 (p<0.01) for tenderness; 42.5 to 15.9 (p<0.01) for swelling. Joint swelling reduced further to a value of 13.0 (p<0.001) by week 4. Patients fatigue decreased from 5.32 to 3.35 (p<0.05) over the month and a feeling of satisfaction in ones ability to do activities was apparent after 1 week, 3.1 to 2.5 (p<0.01) and persisted. No laboratory tests indicative of gold toxicity were noted. One patient reported 2 chancre sores which cleared while on therapy, 8 of 10 patients responded to colloidal gold.
Zusammenfassung:
In dieser Pilotstudie wurde festgestellt, dass kolloidales Gold (Aurasol-tm) schnell wirkt (innerhalb einer Woche), indem es die Empfindlichkeit und Schwellung der Gelenke reduziert, ohne Nebenwirkungen, das Gefühl der Zufriedenheit in der Fähigkeit, Aktivitäten auszuführen, verbessert und die Müdigkeit bei 8 von 10 Patienten mit lang anhaltender erosiver RA reduziert. Die Studie wird für ein Jahr fortgesetzt. Es sollen nun weitere definitive kontrollierte Studien mit kolloidalem Gold durchgeführt werden.
Conclusion:
In this pilot study colloidal gold (Aurasol-tm) was found to be rapid acting (within one week) by reducing joint tenderness and swelling, without side effects, improved ones feeling of satisfaction in the ability to perform activities and reduce fatigue in 8 out of 10 patients with long standing erosive RA. The study will continue for one year. More definitive controlled trials should now be undertaken with colloidal gold.
Note:
The study has now completed its eighth month with all ten of the original patients still enrolled. The patients continue to do well with no significant side effects noted. This data is being compiled to be submitted for publication.
Anti-glycation Effect of Gold Nanoparticles on Collagen
Ji-hoon Kim, Chung-Oui Hong, Yun-chang Koo, Hee-Don Choi, Kwang-Won Lee February 2012: Biological & Pharmaceutical Bulletin 35(2):260-4 DOI: 10.1248/bpb.35.260
Source: PubMed
Abstract
Gold-Nanopartikeln (GNPs) wird eine Vielzahl von biologischen Effekten zugeschrieben, darunter entzündungshemmende und antioxidative Aktivitäten. Das Ausmaß einer in vitro Glykationsreaktionsmischung aus Kollagen und Glykolaldehyd wurde untersucht, um die Hemmung der Bildung von Glykolaldehyd-abgeleiteten fortgeschrittenen Glykationsendprodukten (Glykol-AGEs) mit GNPs in Kollagen zu untersuchen, das ein Hauptproteinbestandteil der menschlichen Dermis ist. GNP-behandeltes Kollagen zeigte signifikant weniger Glykation (56,3±4,2%) als eine unbehandelte Glykationskontrolle. Darüber hinaus verringerte die GNP-behandelte Glykation in einem Kollagen-Gittermodell signifikant die AGEs-Verteilung im Modellsystem. Zusammengenommen deuten diese Ergebnisse darauf hin, dass GNPs das Potenzial haben, bei der Prävention der Glykations-induzierten Hautalterung eingesetzt zu werden.
Abstract
Gold nanoparticles (GNPs) have been reported to exhibit a variety of biological effects including anti-inflammatory and anti-oxidant activities. The extent of an in vitro glycation reaction mixture of collagen and glycolaldehyde was assayed to investigate the inhibition of glycolaldehye-derived advanced glycation end products (glycol-AGEs) formation with GNPs in collagen, which is a major protein component of the human dermis. GNP-treated collagen showed significantly less glycation (56.3±4.2%) than an untreated glycation control. Moreover, GNP-treated glycation in a collagen lattice model significantly decreased the AGEs distribution in the model system. Taken together, these results suggest that GNPs have the potential for use in the prevention of glycation-induced skin aging.